However, whether FBP1 acted on the PI3K/AKT pathway to modulate the malignant phenotype and aerobic glycolysis of GBM cells required verification by further rescue assays using relevant agonists or antagonists of PI3K/AKT pathway, and this will the focus of our future study. This evidence concerns the gene FBP1 and glioblastoma.